News
Afatinib has broad activity against EGFR mutations. However, the approval for uncommon mutations was based on data from 38 ...
Shares of GSK PLC GSK slid 4.90% to £13.79 Wednesday, on what proved to be an all-around rough trading session for the stock ...
The ASX has dipped this morning, tracking down 0.23pc. The ASX Gold and Tech indices are on the rise, despite a fall in gold prices overnight.
Novo Nordisk has abandoned gender representation targets in its U.S. operations, citing legal pressures from President ...
Britain's main indexes saw a downturn on Wednesday, driven by declines in healthcare and real estate stocks, even as progress ...
Immutep Limited’s IMMP share price has dipped by 12.04%, which has investors questioning if this is right time to buy.
A new site to house one of the UK's most secretive research centres is being considered by the government. Hundreds of ...
GSK plc's stock price has significantly outperformed the healthcare sector this year, supported by its healthy Q1 2025 ...
On the FDA’s docket this month are two expansion bids, one for GSK’s asthma drug Nucala into COPD and another for Merck’s ...
The chief executive of the Cambridge-headquartered pharmaceutical giant AstraZeneca has urged the European Union to allow the ...
An increasing array of B-cell targeting approaches may aid clinicians in managing the cycles and flares of lupus, according ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results